KAZIA THERAPEUTICS LTD (KZIA) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 8, 2026 filed Jan. 8, 2026 | Bonacorda Jeffrey VP, Finance and Controller | $0 | 150,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed Jan. 8, 2026 | Coffey Steven R. S. Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed Jan. 8, 2026 | Friend John E. II Chief Executive Officer | $0 | 650,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed Jan. 8, 2026 | Davidson Ebru Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| July 8, 2026 filed Jan. 8, 2026 | Cain David Director, CMC | $0 | 100,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free